Comparison of AWBAT™-D & MEPILEX® AG for Treatment of Donor Sites in Burn

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03590873` - The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients	N/A
Recruiting	`NCT03884036` - Effect of Vitamin D in Burn Patients	N/A
Not yet recruiting	`NCT05241912` - Supernormal Oxygen Delivery for Patients With Severe Burns	Early Phase 1

See also

Status

Clinical Trial

Phase

Recruiting

NCT03590873 - The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients

N/A

Recruiting

NCT03884036 - Effect of Vitamin D in Burn Patients

N/A

Not yet recruiting

NCT05241912 - Supernormal Oxygen Delivery for Patients With Severe Burns

Early Phase 1

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00974597
Study type	Interventional
Source	Aubrey Inc.
Contact
Status	Terminated
Phase	N/A
Start date	September 2009

Comparison of AWBAT™-D and MEPILEX® AG for Treatment of Donor Sites in Burn Surgery

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms